All Studies

Therapeutic and palliative role of a Unani herbal decoction in COVID-19 and similar respiratory viral illnesses: Phytochemical & pharmacological perspective.

Outbreaks of respiratory viruses like SARS, MERS, and COVID-19 have been frequent over the last century, causing many deaths due to complications. Traditional medicines have been observed to offer palliative and therapeutic benefits, including for COVID-19. The Unani herbal decoction, comprising of three fruits/seeds, was originally prescribed for respiratory ailments in the early 1900s and was recently prescribed by the Indian government for mild COVID-19 patients in home isolation. Preliminary studies suggest that the decoction could reduce COVID-19 incidence and severity.

Fazil M and Nikhat S (2022).
J Ethnopharmacol.
PubMed:
35843408

1,2,3,4,6-Pentagalloyl glucose of Pistacia lentiscus can inhibit the replication and transcription processes and viral pathogenesis of SARS-COV-2.

Researchers examined the effects of five active compounds from Pistacia sp. on key targets of the SARS-COV-2 virus. 1,2,3,4,6-pentagalloyl glucose (PG) was found to be the most effective, with strong binding affinities to helicase, RdRp, E protein, and 3CLpro, and was able to inhibit the replication and transcription processes, making it a potential antiviral treatment. The study suggests PG could also have anti-inflammatory and antioxidant properties.

Samandar F et al (2022).
Mol Cell Probes.
PubMed:
35843391

Development of a validated high-performance thin-layer chromatography method for quantification of lupeol from different parts of Bauhinia acuminata.

Nakkala K and Laddha KS (2022).
Biomed Chromatogr.
PubMed:
35837756

Rosa laevigata Attenuates Allergic Asthma Exacerbated by Water-Soluble PM by Downregulating the MAPK Pathway.

Water-soluble particulate matter (WPM) with heavy metals triggers severe inflammation and worsens asthma. Oral and intratracheal administration of RL reduces inflammation, secretion of cytokines, and IgE, suggesting potential as an asthma treatment.

Ko HM et al (2022).
Front Pharmacol.
PubMed:
35837279